Anthrax Vaccine Research

Verma A, McNichol B, Dominguez-Castillo RI, Amador-Molina JC, Arciniega JL, Reiter K, Meade BD, Ngundi MM, Stibitz S, Burns DL: Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen. Infect. Immun. 2013, 81(1):278-284.

Wagner L, Verma A, Meade BD, Reiter K, Narum DL, Brady RA, Little SF, Burns DL: Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant. Clin. Vaccine Immunol. 2012, 19(9):1465-1473.

Ngundi MM, Meade BD, Little SF, Quinn CP, Corbett CR, Brady RA, Burns DL: Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action. Clin. Vaccine Immunol. 2012, 19(5):731-739.

Ngundi MM, Meade BD, Lin TL, Tang WJ, Burns DL: Comparison of three anthrax toxin neutralization assays. Clin. Vaccine Immunol. 2010, 17(6):895-903.

Brady RA, Verma A, Meade BD, Burns DL: Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays. Clin. Vaccine Immunol. 2010, 17(9):1390-1397.

Verma A, Ngundi MM, Meade BD, De Pascalis R, Elkins KL, Burns DL: Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin. Vaccine Immunol. 2009, 16(10):1405-1412.

Omland KS, Brys A, Lansky D, Clement K, Lynn F, The Participating Laboratories: Inter-laboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species. Clin. Vaccine Immunol. 2008, 15(6):946-953.